Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis.
Journal: Neurourology and urodynamics
Published: January 30, 2024
An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device.
Journal: Journal of endourology
Published: September 07, 2022
Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions.
Journal: Neurourology and urodynamics
Published: February 24, 2021
Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical Trial.
Journal: Female pelvic medicine & reconstructive surgery
Published: July 16, 2020
Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS.
Journal: Neurology
Published: July 27, 2017
The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naïve Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double-Blind Phase 3b Trial.
Journal: The Journal of urology
Published: January 24, 2017
Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment.
Journal: The Journal of urology
Published: April 04, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026